Skip to content

Diagnostic Medicine in Brazil Final Customers Identification

Customers Categorization

Based on the analysis of the value chain for the Diagnostic Medicine industry in Brazil, the final customers can be categorized into two primary segments: Business-to-Consumer (B2C) and Business-to-Business (B2B). These segments represent the ultimate recipients of diagnostic information or the entities that procure these services for a population or for use within their own operations.

B2C Customers:

The primary B2C customers are Patients. These are the individuals who directly undergo diagnostic tests and procedures. They are at the end of the service delivery chain, receiving the results and interpretations that inform their personal health decisions and treatment pathways. Patients access diagnostic services through various avenues within the Brazilian healthcare system, including the public Sistema Único de Saúde (SUS), the supplementary health system (via private insurance), or by paying directly (self-pay).

B2B Customers:

B2B customers in the diagnostic medicine value chain are organizations or entities that purchase or utilize diagnostic services or information for the benefit of a group of individuals, or as part of their operational processes. This category includes:

  • Health Insurance Operators (Operadoras de Saúde): These large private entities are significant B2B customers. They contract with diagnostic service providers to offer covered diagnostic procedures to their beneficiaries. Their business model relies on managing a network of accredited providers and processing claims for services rendered.
  • Public Healthcare System (SUS): Represented by governmental bodies such as the Ministry of Health and State and Municipal Health Secretariats, the SUS is a major B2B customer. It procures diagnostic services, either through its own public facilities or by contracting private diagnostic providers, to offer universal access to the Brazilian population.
  • Hospitals and Clinics: Both public and private hospitals and clinics act as B2B customers. They may have integrated diagnostic departments (laboratories and imaging centers) that procure equipment and reagents from manufacturers and distributors, or they may contract with external diagnostic service providers for specialized tests or imaging services.
  • Companies (for Corporate and Occupational Health): Businesses that require diagnostic testing for their employees, such as pre-employment screenings, periodic health check-ups, or occupational disease surveillance programs, function as B2B customers, contracting with diagnostic service providers.
  • Other Laboratories: Smaller or less specialized laboratories that send out samples for specific or high-complexity tests to larger or specialized reference laboratories are also B2B customers in this context.
  • Physicians: While physicians are healthcare professionals, in their role of requesting diagnostic tests and utilizing the resulting reports to manage patient care, they function as key B2B interfaces for diagnostic service providers. They are critical customers of the diagnostic information provided in the reports.

Detailed profiles of customer characteristics and demographics

Based on the provided text, we can outline the characteristics and demographics of these final customer segments:

B2C Customers: Patients

  • Characteristics: Patients are individuals seeking diagnostic information for various health reasons, including disease detection, diagnosis, treatment monitoring, and preventative health. Their needs vary based on age, health status, medical condition, and the specific diagnostic tests required.
  • Demographics & Access: The patient demographic is as diverse as the Brazilian population itself, a nation with a large and aging population. Access to diagnostic services is influenced by whether they rely on the public SUS, have private supplementary health insurance (covering approximately 25% of the population), or pay directly. Significant disparities exist in access based on geography (urban vs. rural) and socioeconomic status, impacting the timeliness and range of services available to them. Brazilians underwent a total of 2.4 billion diagnostic exams in 2023, with 1.2 billion performed in the private sector. Demand is driven by factors such as rising incidences of chronic diseases and increased health awareness.

B2B Customers:

  • Health Insurance Operators:
    • Characteristics: These are large private financial entities (e.g., Bradesco Saúde, SulAmérica, Amil, Hapvida). They are risk-managing organizations that collect premiums and are significant payers for diagnostic services, which accounted for 21.1% of their expenses in 2023. They are regulated by the National Supplementary Health Agency (ANS). Their focus is on managing costs while providing contracted services to their beneficiaries.
    • Demographics (of beneficiaries): Their customer base (beneficiaries) comprises individuals and groups (often employees of contracting companies) who can afford or are provided with private health insurance, typically representing a segment with higher socioeconomic status compared to the average SUS user.
  • Public Healthcare System (SUS):
    • Characteristics: A vast, government-funded system (federal, state, and municipal) aiming to provide universal healthcare access to all Brazilians. It operates public health facilities and contracts private providers to meet demand. The system often faces challenges related to funding constraints, long waiting times, and potentially outdated infrastructure in some areas. It relies on official fee schedules (e.g., Tabela SUS) for reimbursement.
    • Demographics (of users): Serves the majority of the Brazilian population, including those who do not have access to supplementary health insurance. Users come from all demographic segments, with a significant portion from lower socioeconomic strata.
  • Hospitals and Clinics:
    • Characteristics: These range from large, integrated private hospital networks (like Rede D'Or São Luiz) to smaller independent clinics and public hospitals. Their diagnostic needs vary based on their size, specialty, patient volume, and whether they have in-house diagnostic capabilities or outsource services. They require timely and accurate diagnostic information for patient care, treatment planning, and monitoring within their facilities.
  • Companies (Corporate and Occupational Health):
    • Characteristics: Businesses across diverse industries. Their diagnostic needs are focused on employee health and safety, compliance with occupational health regulations, and sometimes as a benefit offering to employees. They require efficient and reliable services for health screenings and specific occupational testing.
  • Other Laboratories:
    • Characteristics: Typically smaller or medium-sized independent laboratories or specialized labs that may not have the equipment or expertise for all types of diagnostic tests. They require access to reliable reference laboratory services to offer a broader menu of tests to their own patients and referring physicians.
  • Physicians:
    • Characteristics: Medical professionals across all specialties. They are the primary requesters of diagnostic tests and the key interpreters of diagnostic reports. Their need is for accurate, timely, and clinically relevant diagnostic information to guide medical decision-making for their patients. Shortages of specialized professionals like pathologists and radiologists exist in certain areas.

References:

  • Afip: Afip lança unidade de negócios de medicina diagnóstica. https://www.afip.com.br/afip-lanca-unidade-de-negocios-de-medicina-diagnostica/
  • Afip: O Dia Nacional da Filantropia, celebrado em 20 de outubro, é um bom momento para se observar os ganhos do trabalho realizado por entidades filantrópicas como a Afip Medicina Diagnóstica que, há mais de dez anos, é o maior laboratório de análises clínicas da rede ambulatorial do SUS. A marca pertence à AFIP. https://www.afip.com.br/o-dia-nacional-da-filantropia-celebrado-em-20-de-outubro-e-um-bom-momento-para-se-observar-os-ganhos-do-trabalho-realizado-por-entidades-filantropicas-como-a-afip-medicina-diagnostica-que-ha-mais-de-dez-anos-e-o/
  • Associação Brasileira de Medicina Diagnóstica (Abramed): Pesquisa revela que brasileiros realizaram 2,4 bilhões de exames de diagnóstico em 2023. https://abramed.org.br/pesquisa-revela-que-brasileiros-realizaram-24-bilhoes-de-exames-de-diagnostico-em-2023/
  • A expansão dos laboratórios clínicos no Brasil: desafios para 2025. https://www.acclab.com.br/a-expansao-dos-laboratorios-clinicos-no-brasil-desafios-para-2025/
  • Biocon Diagnósticos. https://biocon.com.br/
  • BioTécnica: Home. https://biotecnica.ind.br/
  • BizNews Brasil: Fusão mexe com mercado de medicina diagnóstica: Fleury se une a Pardini e pode ultrapassar Dasa. https://biznews.com.br/fusaofleuryhermespardini/
  • Conrad: Perspectivas da medicina diagnóstica para 2025. https://conradweb.com.br/perspectivas-da-medicina-diagnostica-para-2025/
  • Conselho Federal de Medicina: Aumento recorde no total de médicos no País pode ser cenário de risco para a assistência, avalia Conselho Federal de Medicina. https://portal.cfm.org.br/noticias/aumento-recorde-no-total-de-medicos-no-pais-pode-ser-cenario-de-risco-para-a-assistencia-avalia-conselho-federal-de-medicina/
  • CRM-PB: Anatomia Patológica: já ouviu falar?. https://www.crmpb.org.br/anatomia-patologica-ja-ouviu-falar/
  • DNEDX: Home page. https://dnedx.com.br/
  • Erba Mannheim Brasil – A ERBA Manheimm oferece soluções de diagnóstico de saúde humana de alto padrão com custo acessível. https://www.erbamanheim.com.br/
  • Estadão: Fusões e aquisições no setor de saúde disparam no 1º trimestre, diz PwC. https://www.estadao.com.br/economia/fusoes-e-aquisicoes-no-setor-de-saude-disparam-no-1-trimestre-diz-pwc/
  • FGV EAESP: Impacto Da Criação Da Associação Brasileira De Medicina Diagnóstica (Abramed) Como Estratégia De Competitividade No Setor Privado De Serviços Diagnósticos No Brasil. https://bibliotecadigital.fgv.br/dspace/handle/10438/18544
  • FORTA TECH: Equipamentos de diagnóstico e reparo para profissionais. https://fortatech.com.br/equipamentos-de-diagnostico/
  • Futuro da Saúde: Medicina diagnóstica: o que esperar do setor nos próximos anos. https://futurodasude.com.br/medicina-diagnostica-o-que-esperar-do-setor/
  • Gestão da Inovação em Medicina Diagnóstica: um Estudo de Caso - Biblioteca Digital de Teses e Dissertações da USP. https://www.teses.usp.br/teses/disponiveis/5/5135/tde-10022016-112854/public/Leonardo_Bonato_Perez_Corrigida.pdf
  • Gold Analisa Diagnóstica - Produtos para uso diagnóstico in vitro - Minas Gerais - Brasil. https://goldanalisa.com.br/
  • Histocell: Soluções em Anatomia Patológica. https://histocell.com.br/
  • Hospital São Paulo: Saúde Suplementar. https://hospitalsaopaulo.org.br/saude-suplementar
  • Hospital Sírio-Libanês: Tendências da Saúde para 2025: novidades e o que deve vir. https://hospitalsiriolibanes.org.br/resources/publicacoes/tendencias-da-saude-para-2025-novidades-o-que-deve-vir/
  • Inopat: Conheça um pouco mais sobre nós e sobre nossos serviços. https://www.inopat.com.br/a-inopat/
  • Interfarma: Medicina diagnóstica tem papel decisivo na saúde suplementar. https://interfarma.org.br/noticias/medicina-diagnostica-tem-papel-decisivo-na-saude-suplementar
  • Labtest Diagnóstica: Gestão Laboratorial: criando a estratégia para 2024. https://labtest.com.br/blog/gestao-laboratorial-criando-a-estrategia-para-2024/
  • Medicina SA: Mercado de dispositivos médicos e diagnóstico in-vitro cresceu 57,9%. https://medicinasa.com.br/mercado-dispositivos-medicos/
  • Ministério da Saúde - Portal Gov.br: Protocolos Clínicos e Diretrizes Terapêuticas - PCDT. https://www.gov.br/saude/pt-br/assuntos/protocolos-clinicos-e-diretrizes-terapeuticas-pcdt
  • Mobilemed: Tendências e desafios da Medicina Diagnóstica. https://mobilemed.com.br/tendencias-e-desafios-da-medicina-diagnostica/
  • Mordor Intelligence: Tamanho do mercado de diagnóstico in vitro do Brasil e análise de ações – Tendências e previsões de crescimento (2024 - 2029). https://www.mordorintelligence.com/pt/industry-reports/brazil-in-vitro-diagnostics-market
  • Mordor Intelligence: Tamanho do mercado de patologia anatômica e análise de ações- Relatório de pesquisa da indústria- Tendências de crescimento. https://www.mordorintelligence.com/pt/industry-reports/anatomical-pathology-market
  • Percepção de Valor em Serviços de Medicina Diagnóstica. https://www.saudebusiness.com/gestao/percepcao-de-valor-em-servicos-de-medicina-diagnostica
  • Portal Afya: Quais as expectativas de novidades para a área da saúde em 2025?. https://conteudos.afya.com.br/quais-as-expectativas-de-novidades-para-a-area-da-saude-em-2025
  • Revistas PUC-SP: O segmento da medicina diagnóstica no Brasil. https://revistas.pucsp.br/RFCMS/article/download/26500/18754/62758
  • Roche: Diagnóstica - Roche. https://www.roche.com.br/pt/diagnostica.html
  • Saúde Business: Medicina diagnóstica: perspectivas otimistas para o próximo ano. https://www.saudebusiness.com/gestao/medicina-diagnostica-perspectivas-otimistas-para-o-proximo-ano
  • Saúde Business: Fusões e aquisições no setor de saúde ganham impulso em 2024. https://www.saudebusiness.com/fusoes-e-aquisicoes/fusoes-e-aquisicoes-no-setor-de-saude-ganham-impulso-em-2024
  • Shift: Tendências na medicina diagnóstica para 2025: inovação, eficiência e foco no paciente. https://medical.shift.com.br/tendencias-medicina-diagnostica-2025/
  • Shopplab Notícias: O Mercado Brasileiro de Medicina Diagnóstica: um Panorama Atual. https://www.shopplab.com.br/blog/o-mercado-brasileiro-de-medicina-diagnostica-um-panorama-atual/
  • Sullab - Diagnósticos Clínicos. https://www.sullab.com.br/
  • Terra: Com crescimento de 25%, fusões e aquisições no setor de saúde quebram recorde. https://www.terra.com.br/economia/com-crescimento-de-25-fusoes-e-aquisicoes-no-setor-de-saude-quebram-recorde,72a1619778a872bb3f2529c7d709520by1u7137k.html
  • Terra: Fusões e aquisições no setor de saúde devem crescer este ano, com foco regional, diz consultoria. https://www.terra.com.br/economia/fusao-e-aquisicao/fusoes-e-aquisicoes-no-setor-de-saude-devem-crescer-este-ano-com-foco-regional-diz-consultoria,5156b31a6f66c4244878f249604280cahc8432oq.html
  • VEJA: Tendências da medicina para 2025: o que vai mudar nos exames | Letra de Médico. https://veja.abril.com.br/coluna/letra-de-medico/tendencias-da-medicina-para-2025-o-que-vai-mudar-nos-exames
  • Vyttra Diagnósticos: soluções diagnósticas sem fronteiras. https://vyttra.com.br/